BioCrude Technologies USA, Inc. financial data

Industry
Refuse Systems
Location
1255 Phillips Square, Suite 605, Montreal, Quebec, Canada
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.78 % +11570%
Debt-to-equity -116 % -5.71%
Return On Equity 108 % -9.12%
Return On Assets -747 % +49.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.9M shares +0.06%
Common Stock, Shares, Outstanding 50.9M shares +0.11%
Entity Public Float 0 USD
Common Stock, Value, Issued 50.9K USD +0.11%
Weighted Average Number of Shares Outstanding, Basic 50.9M shares +0.15%
Weighted Average Number of Shares Outstanding, Diluted 50.9M shares +0.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 277K USD +15.3%
Operating Income (Loss) -277K USD -15.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -281K USD -15%
Earnings Per Share, Basic -0.01 USD/shares
Earnings Per Share, Diluted -0.01 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.2K USD
Property, Plant and Equipment, Net 13.9K USD -12.8%
Assets 19.1K USD +19.8%
Liabilities, Current 322K USD +26.8%
Liabilities 322K USD +26.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 28.6K USD -0.19%
Retained Earnings (Accumulated Deficit) -9.48M USD -3.05%
Stockholders' Equity Attributable to Parent -299K USD -27.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -303K USD -27.3%
Liabilities and Equity 19.1K USD +19.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -79.4K USD -428%
Net Cash Provided by (Used in) Financing Activities 79.5K USD +430%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 50.9M shares +0.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -26K USD -1550%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 476K USD +13.9%
Depreciation 1.09K USD +6.9%
Payments to Acquire Property, Plant, and Equipment 0 USD
Property, Plant and Equipment, Gross 37.4K USD +7.32%
Additional Paid in Capital 9.1M USD +2.43%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 3.62K USD -3.52%